Acrolein-induced dyslipidemia and acute-phase response are independent of HMG-CoA reductase

Molecular Nutrition and Food Research

Volumn 55, Issue 9, 2011, Pages 1411-1422

  Conklin, Daniel J ^a   Prough, Russell A ^a   Juvan, Peter ^b   Rezen, Tadeja ^b   Rozman, Damjana ^b   Haberzettl, Petra ^a   Srivastava, Sanjay ^a   Bhatnagar, Aruni ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Acute phase response; Aldehyde; Cholesterol; HMG CoA reductase; Lipoproteins

Indexed keywords

ACROLEIN; APOLIPOPROTEIN E; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; INSIG1 PROTEIN, MOUSE; INSIG2 PROTEIN, MOUSE; MEMBRANE PROTEIN; SERUM AMYLOID A; SIMVASTATIN; TRIACYLGLYCEROL; XENOBIOTIC AGENT;

ACUTE PHASE RESPONSE; ANIMAL; ARTICLE; BLOOD; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; DYSLIPIDEMIA; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; LIVER; MALE; METABOLISM; MOUSE; MOUSE MUTANT; TOXICITY TESTING;

ACROLEIN; ACUTE-PHASE REACTION; ANIMALS; APOLIPOPROTEINS E; CHOLESTEROL; DYSLIPIDEMIAS; GENE EXPRESSION REGULATION; HYDROXYMETHYLGLUTARYL COA REDUCTASES; LIVER; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; SERUM AMYLOID A PROTEIN; SIMVASTATIN; TOXICITY TESTS, ACUTE; TOXICITY TESTS, CHRONIC; TRIGLYCERIDES; XENOBIOTICS;

MURINAE; MUS;

EID: 80052543706     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201100225     Document Type: Article

References (34)

1. Feron, V. J., Til, H. P., de Vrijer, F., Woutersen, R. A. et al., Aldehydes: occurrence, carcinogenic potential, mechanism of action and risk assessment. Mutat. Res. 1991, 259, 363-385.
2. Ghilarducci, D. P., Tjeerdema, R. S., Fate and effects of acrolein. Rev. Environ. Contam. Toxicol. 1995, 144, 95-146.
3. Fullana, A., Carbonell-Barrachina, A. A., Sidhu, S., Comparison of volatile aldehydes present in the cooking fumes of extra virgin olive, olive, and canola oils. J. Agric. Food Chem. 2004, 52, 5207-5214.
4. Wang, G. W., Guo, Y., Vondriska, T. M., Zhang, J. et al., Acrolein consumption exacerbates myocardial ischemic injury and blocks nitric oxide-induced PKCepsilon signaling and cardioprotection. J. Mol. Cell Cardiol. 2008, 44, 1016-1022.
5. Conklin, D. J., Barski, O. A., Lesgards, J. F., Juvan, P. et al., Acrolein consumption induces systemic dyslipidemia and lipoprotein modification. Toxicol. Appl. Pharmacol. 2010, 243, 1-12.
6. Srivastava, S., Sithu, S. D., Vladykovskaya, E., Haberzettl, P. et al., Oral exposure to acrolein exacerbates atherosclerosis in apoE-null mice. Atherosclerosis 2011, 215, 301-308.
7. Khovidhunkit, W., Kim, M. S., Memon, R. A., Shigenaga, J. K. et al., Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J. Lipid Res. 2004, 45, 1169-1196.
8. Tous, M., Ribas, V., Ferre, N., Escola-Gil, J. C. et al., Turpentine-induced inflammation reduces the hepatic expression of the multiple drug resistance gene, the plasma cholesterol concentration and the development of atherosclerosis in apolipoprotein E deficient mice. Biochim. Biophys. Acta 2005, 1733, 192-198.
9. Conklin, D. J., Haberzettl, P., Prough, R. A., Bhatnagar, A., Glutathione-S-transferase P protects against endothelial dysfunction induced by exposure to tobacco smoke. Am. J. Physiol. Heart Circ. Physiol. 2009, 296, H1586-H1597.
10. Conklin, D. J., Haberzettl, P., Lesgards, J. F., Prough, R. A. et al., Increased sensitivity of glutathione S-transferase P-null mice to cyclophosphamide-induced urinary bladder toxicity. J. Pharmacol. Exp. Ther. 2009, 331, 456-469.
11. Simoncic, M., Rezen, T., Juvan, P., Rozman, D. et al., Obesity resistant mechanisms in the Lean polygenic mouse model as indicated by liver transcriptome and expression of selected genes in skeletal muscle. BMC Genomics 2011, 12, 96.
12. Rezen, T., Juvan, P., Fon, T. K., Kuzman, D. et al., The Sterolgene v0 cDNA microarray: a systemic approach to studies of cholesterol homeostasis and drug metabolism. BMC Genomics 2008, 9, 76.
13. Rezen, T., Tamasi, V., Lovgren-Sandblom, A., Bjorkhem, I. et al., Effect of CAR activation on selected metabolic pathways in normal and hyperlipidemic mouse livers. BMC Genomics 2009, 10, 384.
14. Demšar, J., Zupan, B., Leban, G., University of Ljubljana, Ljubljana, Slovenia, 2004.
15. Cleveland, W. S., Devlin, S. J., Locally-weighted regression: an approach to regression analysis by local fitting. J. Am. Statis. Assoc. 1988, 83, 596-610.
16. Smyth, G. K., Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 2004, 3, Article3.
17. Benjamini, Y., Hochberg, Y., Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Statistis. Soc. Ser. B 1995, 57, 289-300.
18. Li, H., Wang, J., Kaphalia, B., Ansari, G. A., Khan, M. F., Quantitation of acrolein-protein adducts: potential biomarker of acrolein exposure. J. Toxicol. Environ. Health A 2004, 67, 513-524.
19. Conklin, D. J., Haberzettl, P., Lee, J., Srivastava, S., in: Bhatnagar, A. (Ed.), Environmental Cardiology: Pollution and Heart Disease, Royal Society of Chemistry, London, England. 2011, p. 390.
20. Radhakrishnan, A., Ikeda, Y., Kwon, H. J., Brown, M. S., Goldstein, J. L., Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: oxysterols block transport by binding to Insig. Proc. Natl. Acad. Sci. USA 2007, 104, 6511-6518.
21. Espenshade, P. J., Hughes, A. L., Regulation of sterol synthesis in eukaryotes. Annu. Rev. Genet. 2007, 41, 401-427.
22. Koch, A., Konig, B., Spielmann, J., Leitner, A. et al., Thermally oxidized oil increases the expression of insulin-induced genes and inhibits activation of sterol regulatory element-binding protein-2 in rat liver. J. Nutr. 2007, 137, 2018-2023.
23. Haberzettl, P., Vladykovskaya, E., Srivastava, S., Bhatnagar, A., Role of endoplasmic reticulum stress in acrolein-induced endothelial activation. Toxicol. Appl. Pharmacol. 2009, 234, 14-24.
24. Vesely, P., Lusk, L., Basarova, G., Seabrooks, J., Ryder, D., Analysis of aldehydes in beer using solid-phase microextraction with on-fiber derivatization and gas chromatography/mass spectrometry. J. Agric. Food Chem. 2003, 51, 6941-6944.
25. Amunom, I., Stephens, L. J., Tamasi, V., Cai, J. et al., Cytochromes P450 catalyze oxidation of alpha, beta-unsaturated aldehydes. Arch. Biochem. Biophys. 2007, 464, 187-196.
26. Zannikos, P. N., Bandyopadhyay, A. M., Robertson, L. W., Blouin, R. A., Cytochrome P450 2B enzyme induction defect after 2, 2', 4, 4', 5, 5'-hexachlorobiphenyl treatment in the fa/fa Zucker rat. J. Pharmacol. Exp. Ther. 1994, 268, 1565-1570.
27. Roe, A. L., Warren, G., Hou, G., Howard, G. et al., The effect of high dose endotoxin on CYP3A2 expression in the rat. Pharm. Res. 1998, 15, 1603-1608.
28. Aitken, A. E., Morgan, E. T., Gene-specific effects of inflammatory cytokines on cytochrome P450 2C, 2B6 and 3A4 mRNA levels in human hepatocytes. Drug Metab. Dispos. 2007, 35, 1687-1693.
29. Rencurel, F., Foretz, M., Kaufmann, M. R., Stroka, D. et al., Stimulation of AMP-activated protein kinase is essential for the induction of drug metabolizing enzymes by phenobarbital in human and mouse liver. Mol. Pharmacol. 2006, 70, 1925-1934.
30. Memon, R. A., Moser, A. H., Shigenaga, J. K., Grunfeld, C., Feingold, K. R., In vivo and in vitro regulation of sterol 27-hydroxylase in the liver during the acute phase response. potential role of hepatocyte nuclear factor-1. J. Biol. Chem. 2001, 276, 30118-30126.
31. Sithu, S. D., Srivastava, S., Siddiqui, M. A., Vladykovskaya, E. et al., Exposure to acrolein by inhalation causes platelet activation. Toxicol. Appl. Pharmacol. 2010, 248, 100-110.
32. National Research Council, Committee on Aldehydes, Formaldehyde and other aldehydes, National Academy Press, Washington D.C. 1981.
33. Bhatnagar, A., Cardiovascular pathophysiology of environmental pollutants. Am. J. Physiol. Heart Circ. Physiol. 2004, 286, H479-H485.
34. Stevens, J. F., Maier, C. S., Acrolein: sources, metabolism, and biomolecular interactions relevant to human health and disease. Mol. Nutr. Food Res. 2008, 52, 7-25.